Research overview of Bemagromab (Bimagrumab), an anti-ActRIIB monoclonal antibody studied for muscle preservation, obesity, and metabolic research. For laboratory research use only.
Learn about insulin and glucagon as peptide hormones, the islet paracrine axis, and how GLP-1 interacts with both to regulate blood glucose in metabolic research.
Complete guide to the IGF-1 axis covering the GH-IGF-1 endocrine axis, IGFBPs, IGF-1 LR3 design rationale, local vs systemic signaling, and IGF-1R downstream pathways.
Complete 5-Amino-1MQ research overview covering NNMT inhibition mechanism, NAD+ elevation, adipogenesis suppression, animal metabolic study findings, and comparison to NR and NMN.
Complete research explainer on GLP-1 receptor agonists covering GLP-1 biology, receptor signaling, pancreatic and CNS effects, gastric emptying, cardiovascular outcomes, and half-life extension strategies.
Learn the science of ghrelin and ghrelin mimetics including discovery, octanoylation, GHS-R1a signaling, GH-releasing effects, appetite regulation, and synthetic GHRP research tools.
Complete Kisspeptin research overview covering HPG axis regulation, GnRH gating mechanism, reproductive research applications, metabolic connections, and clinical fertility studies.
Compare Semaglutide and Tirzepatide in this research guide covering GLP-1 vs dual GIP/GLP-1 mechanisms, receptor differences, and comparative metabolic research findings.
Lipo-C is a lipotropic research compound combining methionine, inositol, choline (MIC), and B vitamins, each with established roles in hepatic fat metabolism and VLDL assembly research.
Cagrilintide is a long-acting amylin analogue with a ~7-day half-life, studied standalone and in the CagriSema combination with semaglutide.
